Abstract
The first paper reporting on a potentially important medical property of a non-antimicrobial tetracycline appeared in 1987. Since then, a literature of over 75 papers has supported the therapeutic potential of this class of compounds. In this review, this literature is grouped and organized with commentary on the data which has been published to date. The biomedical applicability of these discoveries obviously covers a wide range of medical conditions and clearly justifies their continued development.
Keywords: Non Antibiotics, Modified tetracycline, antimicrobial properties, enzyme inhibition, animal models, collagenolytic activity, cmts inhibit MMP 13, Enhance cytokine, Cartilage degradation, non specific proteolysis, induce apoptosis, metabolic bone disease, arthritic dog
Current Medicinal Chemistry
Title: Biologic Properties of Non-Antibiotic, Chemically Modified Tetracyclines (CMTs): A Structured, Annotated Bibliography
Volume: 8 Issue: 3
Author(s): Robert A. Greenwald and Lorne M. Golub
Affiliation:
Keywords: Non Antibiotics, Modified tetracycline, antimicrobial properties, enzyme inhibition, animal models, collagenolytic activity, cmts inhibit MMP 13, Enhance cytokine, Cartilage degradation, non specific proteolysis, induce apoptosis, metabolic bone disease, arthritic dog
Abstract: The first paper reporting on a potentially important medical property of a non-antimicrobial tetracycline appeared in 1987. Since then, a literature of over 75 papers has supported the therapeutic potential of this class of compounds. In this review, this literature is grouped and organized with commentary on the data which has been published to date. The biomedical applicability of these discoveries obviously covers a wide range of medical conditions and clearly justifies their continued development.
Export Options
About this article
Cite this article as:
Greenwald A. Robert and Golub M. Lorne, Biologic Properties of Non-Antibiotic, Chemically Modified Tetracyclines (CMTs): A Structured, Annotated Bibliography, Current Medicinal Chemistry 2001; 8 (3) . https://dx.doi.org/10.2174/0929867013373624
DOI https://dx.doi.org/10.2174/0929867013373624 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on DNA & Gene Sequences Conference Report: Summary Report of the International Association of Neurorestoratology VII Conference: Regulations, Ethics, Science, and the Need of Patients Care in Neurorestoratology
CNS & Neurological Disorders - Drug Targets Autoimmune Lymphoproliferative Syndrome (ALPS)
Current Pharmaceutical Design Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy
Current Pharmaceutical Design Developments in HIV Neuropathogenesis
Current Pharmaceutical Design Editorial [Hot Topic: Simian Immunodeficiency Virus Pathogenesis (Guest Editor: Donald Sodora)]
Current HIV Research Recent Advances on the Role of microRNAs in both Insulin Resistance and Cancer
Current Pharmaceutical Design Tyrosinase Electrochemical Biosensors Monitoring Medicinally Significant Substances
Current Medicinal Chemistry Nuclear Receptor SHP as a Potential Therapeutic Target for Liver Cancer
Current Cancer Therapy Reviews Molecular Target-Guided Tumor Therapy with Natural Products Derived from Traditional Chinese Medicine
Current Medicinal Chemistry Fungal Pathogens Research: Novel and Improved Molecular Approaches for the Discovery of Antifungal Drug Targets
Current Drug Targets The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family
Current Pharmaceutical Design Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations
Combinatorial Chemistry & High Throughput Screening A Single Fas Gene Mutation Changes Lupus Onset, Severity, Location, and Molecular Abnormalities in Mice
Current Molecular Medicine The Effects of IGF-1 on Trk Expressing DRG Neurons with HIV-gp120- Induced Neurotoxicity
Current HIV Research Development of Peptide Inhibitors to Block Type I and Type III Collagen-platelet Interaction
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Cell Wall-Associated Proteins in the Dimorphic Pathogenic Species of Paracoccidioides
Current Protein & Peptide Science Bone-Muscle Crosstalk: Unraveling New Therapeutic Targets for Osteoporosis
Current Pharmaceutical Design Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Release of Growth Factors, Cytokines and Therapeutic Molecules by Hyaluronan-based Hydrogels
Current Pharmaceutical Biotechnology